Proscia is a digital pathology company that uses artificial intelligence and machine learning to improve the accuracy and speed of cancer diagnosis. The company's platform allows pathologists to analyze and share digital images of tissue samples, enabling faster and more accurate diagnoses. Proscia's technology has the potential to improve patient outcomes and reduce healthcare costs by enabling earlier detection and more precise treatment of cancer. The company was founded in 2014 and is headquartered in Philadelphia, Pennsylvania.